Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bafetinib is a potent and selective dual inhibitor of Bcr-Abl/Lyn tyrosine kinase (IC50: 5.8nM and 19nM, respectively).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | お問い合わせ | ¥ 16,500 |
10 mg | お問い合わせ | ¥ 30,500 |
25 mg | お問い合わせ | ¥ 52,500 |
100 mg | お問い合わせ | ¥ 105,500 |
1 mL * 10 mM (in DMSO) | お問い合わせ | ¥ 28,500 |
説明 | Bafetinib is a potent and selective dual inhibitor of Bcr-Abl/Lyn tyrosine kinase (IC50: 5.8nM and 19nM, respectively). |
In vitro | Bafetinib is a specific dual Abl-Lyn inhibitor. For 79 other tyrosine kinases, Bafetinib (0.1μM) can inhibit 4 of these enzymes including Abl, Abl-related gene, Fyn, and Lyn. Bafetinib can block the autophosphorylation of Bcr-Abl. In K562 and 293T cells transfected with wt Bcr-Abl, Bafetinib shows inhibition with IC50 values of 11nM and 22nM, respectively. In the in vitro kinase assays, Bafetinib shows inhibition of a variety of Abl kinase mutants such as M244V, G250E, Y253F, and F317L. It has no effect on T315I in vitro. Bafetinib also suppresses the growth of Bcr-Abl–positive leukemic cell lines including K562, KU812, and BaF3/wt. The BaF3/E255K cells are also sensitive towards Bafetinib. Moreover, Bafetinib is highly potent to inhibit tumor growth in murine tumor models [1]. |
分子量 | 576.62 |
分子式 | C30H31F3N8O |
CAS No. | T22597 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: ≥57.7mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bafetinib (INNO-406) T22597 Others Bafetinib (INNO 406) INNO 406 Bafetinib Bafetinib (INNO406) INNO406 INNO-406 Inhibitor inhibitor inhibit